Cresp 40mcg Injection is a medication used to treat anemia, particularly in patients with chronic kidney disease (CKD) who are undergoing dialysis. The active ingredient is Darbepoetin alfa, a long-acting erythropoiesis-stimulating agent (ESA). Darbepoetin alfa works by stimulating the bone marrow to produce more red blood cells, thereby increasing hemoglobin levels and improving the oxygen-carrying capacity of the blood. This helps to alleviate symptoms of anemia such as fatigue, weakness, and shortness of breath.
Cresp 40mcg Injection is administered subcutaneously or intravenously as prescribed by a healthcare professional. The dosage and frequency of administration depend on the individual patient’s condition, hemoglobin levels, and response to treatment. Common side effects may include headache, nausea, vomiting, diarrhea, and pain or redness at the injection site. Less common but serious side effects can include high blood pressure, blood clots, and allergic reactions. Patients should inform their doctor about any pre-existing medical conditions, especially cardiovascular diseases, and any other medications they are taking.
Storage instructions for Cresp 40mcg Injection typically involve keeping it at room temperature (20°C to 25°C or 68°F to 77°F), protected from light. Do not freeze. It should be stored in its original packaging until ready for use. Always follow the specific storage recommendations provided by the manufacturer or your healthcare provider.
